Research Analysts Set Expectations for BIO Q2 Earnings

Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) – Equities researchers at Zacks Research reduced their Q2 2025 EPS estimates for shares of Bio-Rad Laboratories in a research note issued on Thursday, May 22nd. Zacks Research analyst R. Department now forecasts that the medical research company will earn $2.14 per share for the quarter, down from […]

Leave a Reply

Your email address will not be published.

Previous post Zacks Research Has Bearish Forecast for Amgen Q2 Earnings
Next post Zacks Research Analysts Decrease Earnings Estimates for PPL